Irfan Baki Kilic

1PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 11, 2025
Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell expansion.

Irfan Baki Kilic, Petra Weberova, Derek VanDyke

Pageof 1

Frequent Collaborators

1 joint publications

Jamie B Spangler

1 joint publications

Marek Kovar